The EASL Liver Cancer Summit 2023 took place in Estoril, Portugal from 20-22 April and online. Liver cancer is a major health problem and hepatocellular carcinoma (HCC) is considered one of the leading causes of cancer-related deaths worldwide. It is…
Under the patronage of the Slovenian presidency of the Council of the European Union, the European Association for Study of the Liver (EASL) and the European Liver Patients’ Association (ELPA) are organising an advocacy event with the support of: University…
Use your EASL Campus account or create a free one if you don't have an account yet and browse through 180 resources. Click on the banner below to access the content.
We are delighted to announce the EASL–AASLD HCC Endpoints meeting on clinical trial design and endpoints in hepatocellular carcinoma (HCC), taking place as a virtual meeting 28–29 October 2021. Despite recent advances in the medical management of HCC, it still remains a major healthcare problem. HCC prevention, early detection, and clinical management are challenging in a space where scientific advances are…
